Department of Surgery, Inst of Clinical Sciences
Gothenburg, SE413 45, Sweden
NCT Number: NCT00329615
The study is designed to evaluate whether daily insulin treatment to weight losing cancer patients attenuates progression of cancer cachexia and improves metabolism.
Looking for future studies?
Notify Me25 year–85 year
All sexes
Interventional
Phase 4
Gothenburg, SE413 45, Sweden
Randomized study with long-term follow-up based on survival, health related quality of life, food intake, resting energy expenditure, body composition, exercise capacity and measurement of metabolic efficiency.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Göteborg University
Other
Insulin Treatment in Cancer Cachexia: Effects on Survival, Metabolism and Physical Functioning. A Randomized Prospective Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06476197
Cancer Cachexia
Ilsan, Gyeonggi-do, South Korea
View Trial DetailsNCT04153019
Cancer Cachexia
Reggio Emilia, Emilia-Romagna, Italy
View Trial DetailsNCT06651125
Behavior, Cancer Cachexia
Rennes, Brittany Region, France
View Trial DetailsNCT01614990
Cancer Cachexia
Seattle, Washington, United States
View Trial Details